Fitch Affirms Royalty Pharma plc at 'BBB-'; Outlook Stable
Fitch Ratings has affirmed Royalty Pharma plc's Long-Term Issuer Default Rating at 'BBB-' and the 'BBB-' debt ratings on its existing senior unsecured notes. The Rating Outlook is Stable. Fitch's...